Prosecution Insights
Last updated: April 19, 2026
Application No. 18/269,774

AUTOMATIC ANALYSIS DEVICE AND METHOD FOR CONTROLLING SAME

Non-Final OA §102§103
Filed
Jun 27, 2023
Examiner
MONTGOMERY, ANN Y
Art Unit
1678
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
Hitachi High-Tech Corporation
OA Round
1 (Non-Final)
70%
Grant Probability
Favorable
1-2
OA Rounds
3y 10m
To Grant
96%
With Interview

Examiner Intelligence

Grants 70% — above average
70%
Career Allow Rate
457 granted / 657 resolved
+9.6% vs TC avg
Strong +26% interview lift
Without
With
+26.5%
Interview Lift
resolved cases with interview
Typical timeline
3y 10m
Avg Prosecution
24 currently pending
Career history
681
Total Applications
across all art units

Statute-Specific Performance

§101
1.5%
-38.5% vs TC avg
§103
44.3%
+4.3% vs TC avg
§102
18.1%
-21.9% vs TC avg
§112
17.9%
-22.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 657 resolved cases

Office Action

§102 §103
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Applicant’s election without traverse of Group I (claims 1-7) in the reply filed on 3/18/26 is acknowledged. Claim 8 is withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected invention, there being no allowable generic or linking claim. Claim Interpretation The following is a quotation of 35 U.S.C. 112(f): (f) Element in Claim for a Combination. – An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The following is a quotation of pre-AIA 35 U.S.C. 112, sixth paragraph: An element in a claim for a combination may be expressed as a means or step for performing a specified function without the recital of structure, material, or acts in support thereof, and such claim shall be construed to cover the corresponding structure, material, or acts described in the specification and equivalents thereof. The claims in this application are given their broadest reasonable interpretation using the plain meaning of the claim language in light of the specification as it would be understood by one of ordinary skill in the art. The broadest reasonable interpretation of a claim element (also commonly referred to as a claim limitation) is limited by the description in the specification when 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is invoked. As explained in MPEP § 2181, subsection I, claim limitations that meet the following three-prong test will be interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph: (A) the claim limitation uses the term “means” or “step” or a term used as a substitute for “means” that is a generic placeholder (also called a nonce term or a non-structural term having no specific structural meaning) for performing the claimed function; (B) the term “means” or “step” or the generic placeholder is modified by functional language, typically, but not always linked by the transition word “for” (e.g., “means for”) or another linking word or phrase, such as “configured to” or “so that”; and (C) the term “means” or “step” or the generic placeholder is not modified by sufficient structure, material, or acts for performing the claimed function. Use of the word “means” (or “step”) in a claim with functional language creates a rebuttable presumption that the claim limitation is to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites sufficient structure, material, or acts to entirely perform the recited function. Absence of the word “means” (or “step”) in a claim creates a rebuttable presumption that the claim limitation is not to be treated in accordance with 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. The presumption that the claim limitation is not interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, is rebutted when the claim limitation recites function without reciting sufficient structure, material or acts to entirely perform the recited function. Claim limitations in this application that use the word “means” (or “step”) are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. Conversely, claim limitations in this application that do not use the word “means” (or “step”) are not being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, except as otherwise indicated in an Office action. This application includes one or more claim limitations that do not use the word “means,” but are nonetheless being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, because the claim limitation(s) uses a generic placeholder that is coupled with functional language without reciting sufficient structure to perform the recited function and the generic placeholder is not preceded by a structural modifier. Such claim limitation(s) is/are: a specimen dispensing probe in claim 1 (and dependent claims 2-7); and a control unit in claim 1 (and dependent claims 2-7). Because this/these claim limitation(s) is/are being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, it/they is/are being interpreted to cover the corresponding structure described in the specification as performing the claimed function, and equivalents thereof. If applicant does not intend to have this/these limitation(s) interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph, applicant may: (1) amend the claim limitation(s) to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph (e.g., by reciting sufficient structure to perform the claimed function); or (2) present a sufficient showing that the claim limitation(s) recite(s) sufficient structure to perform the claimed function so as to avoid it/them being interpreted under 35 U.S.C. 112(f) or pre-AIA 35 U.S.C. 112, sixth paragraph. Examiner notes that a specimen dispensing probe in claim 1 (and dependent claims 2-7) is interpreted to be any of the dispensing probes as disclosed in the specification (as originally filed) such as in paragraphs 0013-0015 and 0022), and their equivalents. Moreover, a control unit in claim 1 (and dependent claims 2-7) is interpreted to be any of the control units disclosed in the specification such as in paragraphs 0019, 0021, 0025, 0026, and 0029, and their equivalents. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1, 2 and 4-7 is/are rejected under 35 U.S.C. 102(a)(1) and (a)(2) as being anticipated by US 20190151841 (hereinafter “Iwashita”). As to claim 1, Iwashita discloses an automatic analysis device [see system in para. 0012, for example] for analyzing a specimen, comprising: a specimen dispensing probe configured to dispense an upper layer sample of a specimen [see for example para. 0098 disclosing the pipette to be injecting into a flowpath (thus showing the pipette is configured to dispense], that is separated into the upper layer sample and a lower layer sample, from a specimen container storing the specimen into a reaction container [see for example para. 0085 disclosing a pipette chip that is positioned in a liquid injection section, wherein the pipette chip is capable of sucking liquid]; and a control unit configured to control an operation of the specimen dispensing probe [see para. 0012 disclosing a pipette controller that causes the pipette to perform injection and suction multiple times; see also para. 0098 disclosing the same], wherein the control unit causes the specimen dispensing probe to remove a part of a surface layer of the upper layer sample or apply a vibration to the surface layer of the upper layer sample, and then dispense the upper layer sample from the specimen container to the reaction container for a specific test [see for example para. 0091 disclosing that the liquid in the liquid injection section may be sucked into pipette chip while pipette chip is moved toward the bottom of liquid injection section]. (Examiner notes that paragraph 0091 shows that that the pipette chip is controlled such that liquid is sucked into the pipette chip towards the top of the liquid injection section, and thus is the pipette chip is capable of removing a part of a surface layer of the upper layer sample. Also, the Iwashita pipette controller is capable of performing injection and suction multiple times (see para. 0012 and 0098). Examiner notes that the injection and suction multiple times is equivalent to the repeat of the aspirating and discharging which would apply a vibration to the surface layer of the liquid. As to claim 2, Iwashita discloses that the control unit causes the specimen dispensing probe to remove the upper layer sample of an amount exceeding a threshold value from the surface layer, and then dispense the upper layer sample [capable of being used] for the specific test. See paragraph 0012 and 0098 disclosing a controller to control the pipette chip; and see paragraph 0091 disclosing the control of the pipette chip. Examiner notes that a threshold value is not specified in claim 2, and thus the disclosure by Iwashita meets the limitations of claim 2 as discussed above. Applicant’s claim 4 recites that the part of the upper layer sample removed from the surface layer is used for a test other than the specific test. Examiner notes that claim 4 is directed to a device, and these limitations of claim 4 including use of the control unit and dispensing probe for performing tests, is interpreted to be an intended use. The Iwashita device is capable of performing the intended use since it is capable of removing an upper layer of liquid (see discussion of claim 1 above). Applicant’s claim 5 recites that the specific test is measurement of a lactate dehydrogenase or an alkaline phosphatase. Examiner notes that claim 5 is directed to a device, and these limitations of claim 5 including use of the control unit and dispensing probe for performing test, is interpreted to be an intended use. The Iwashita device is capable of performing the intended use since it is capable of removing and dispensing any liquid reagents into a reaction vessel (see discussion of claim 1 above). Applicant’s claim 6 recites that the control unit causes the specimen dispensing probe to repeat aspirating and discharging with respect to the surface layer so as to apply a vibration to the surface layer, and then dispense the upper layer sample for the specific test. As discussed above regarding claim 1, the Iwashita pipette controller is capable of performing injection and suction multiple times (see para. 0012 and 0098). Examiner notes that the injection and suction multiple times is equivalent to the repeat of the aspirating and discharging which would apply a vibration to the surface layer of the liquid. The Iwashita pipette is capable of aspirating an upper layer sample. Any of the subsequent discharging is equivalent to the dispensing the upper layer sample. Applicant’s claim 7 recites that the control unit causes the specimen dispensing probe to repeat lowering and raising to come into contact with the surface layer a plurality of times so as to apply a vibration to the surface layer, and then dispense the upper layer sample for the specific test. See Iwashita in paragraph 0085 disclosing that the pipette placed in an injection section, the position is sensed, and the pipette is moved downward, with this operation being repeated until the desired threshold. See paragraph 0086 disclosing that the pipette is moved upwards. Thus the Iwashita pipette is capable of being moved upward and downward, repeatedly, thus meeting Applicant’s claim. Also the Iwashita pipette is capable of aspirating an upper layer sample. Any of the subsequent discharging is equivalent to the dispensing the upper layer sample. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 3 is/are rejected under 35 U.S.C. 103 as being unpatentable over US 20190151841 (hereinafter “Iwashita”). Applicant’s claim 3 recites that the threshold value is set based on a depth of a suspended matter floating in the surface layer of the upper layer sample and an inner diameter of the specimen container. Providing the Iwashita pipette controller such that the pipette chip removes an amount of liquid sample as recited falls within a workable range of the Iwashita invention. Moreover, it would have been predictable by one skilled in the art that setting the threshold value for removing the liquid sample as recited would remove a desired amount of liquid sample for a particular assay. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to Ann Montgomery whose telephone number is (571)272-0894. The examiner can normally be reached Mon-Fri, 9-5:30 PM PST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Greg Emch can be reached at 571-272-8149. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Ann Montgomery/Primary Examiner, Art Unit 1678
Read full office action

Prosecution Timeline

Jun 27, 2023
Application Filed
Apr 04, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12590960
IMMUNOASSAY TEST DEVICE WITH TWO FLUID FLOW PATHS FOR DETECTION AND DIFFERENTIATION OF TWO OR MORE ANALYTES
2y 5m to grant Granted Mar 31, 2026
Patent 12575772
DEVICES AND METHODS FOR BODILY FLUID COLLECTION AND DISTRIBUTION
2y 5m to grant Granted Mar 17, 2026
Patent 12570947
BUFFER PREPARATION AND TRANSFER SYSTEM FOR ANTIBODY DRUG MANUFACTURING PROCESS
2y 5m to grant Granted Mar 10, 2026
Patent 12566183
DETECTION OF BIOMARKERS ON VESICLES FOR THE DIAGNOSIS AND PROGNOSIS OF DISEASES AND DISORDERS
2y 5m to grant Granted Mar 03, 2026
Patent 12560598
CARTRIDGE-BASED AUTOMATED RAPID TEST ANALYZER
2y 5m to grant Granted Feb 24, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
70%
Grant Probability
96%
With Interview (+26.5%)
3y 10m
Median Time to Grant
Low
PTA Risk
Based on 657 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month